Northwest Biotherapeutics reported $-13.41M in EBITDA for its fiscal quarter ending in September of 2023.





Ebitda Change Date
Agenus USD -10.11M 19.02M Mar/2025
AstraZeneca USD 7.46B 2.3B Sep/2026
Bristol-Myers Squibb USD 3.48B 1.6B Sep/2026
Celldex Therapeutics USD -79.72M 3.86M Jun/2026
Eisai JPY 25.94B 8.21B Sep/2026
Merck USD 1.42B 2.97B Jun/2026
Northwest Biotherapeutics USD -13.41M 232K Sep/2023
Pfizer USD 6.36B 350M Sep/2026
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Roche Holding CHF 13.43B 744M Jun/2026